Marksans Pharma Ltd. — AGM Information 2021

Sep 23, 2021

•• Marksaris Pharma Ltd.

BSE Limited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-l, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS

Pursuant to Regulation 30 read with Part-A of Schedule-III of SEBI (Listing Obligations and Disclosures Requirements), 2015 we enclose herewith in the prescribed format Summary of proceedings of the 29[th] Annual General Meeting of Marksans Pharma Limited held today i.e. Thursday, 23[rd] September, 2021 at 09:00 A.M. through Video Conferencing lather Audio Visual means (VC).

Yours faithfully, For Marksans Pharma Limited 0. r\J) ~.J~ Harshavardhan Panigrahi Company Secretary

Marksans Pharma Ltd.

11th Floor, "GRANDEUR", Opp. Gundecha Symphony,Veera Desai Extension Road Oshiwara Andheri (W), Mumbai - 400 053 • Tel.: +91 224001 2000 • E-mail: info@marksanspharma.co.;. www.marksanspharma.com

Summary of proceedings of the 29[th] Annual General Meeting of Marksans Pharma Limited held on Thursday, 23[rd] September, 2021 at 09:00 AM through Video Conferencing / Other Audio Visual means evC)

This is to inform you that the 29[th] Annual General Meeting ("AGM") of Marksans Pharma Limited ("the Company") was held today i.e. Thursday, 23[rd] September, 2021 at 09:00 A.M. through VC and the businesses mentioned in the Notice dated August 11,2021 were transacted.

The AGM of the Members of the Company was held on Thursday, 23[rd] September, 2021 at 09:00 A.M. through Video Conferencing / Other Audio Visual means (VC). For the purpose of recording the proceedings, the AGM was deemed to held at the registered office of the Company at 11 th Floor, Grandeur, Veera Desai Extension Road, Oshiwara, Andheri (W), Mumbai, India.

• b. Mr. Harshavardhan Panigrahi, Company Secretary explained the procedure for conducting the meeting through VC as well as voting during the AGM.

• c. The Chairman informed that all the Directors of the Company & Mr. Jitendra Sharma, Chief Financial Officer had joined the meeting from their respective locations. The Chairman further informed that Mr. Digant Mahesh Parikh, Chairman of the Audit Committee and Mr. S. R. Buddharaju, Chairman of the Stakeholder Relationship Committee and the Nomination and Remuneration Committee attended the AGM from their respective locations. The Chairman further informed that authorised representative of Statutory Auditor, Secretarial Auditor and Scrutinizer had alsojoined the meeting from their respective locations.

• e. The Chairman informed that due to the social distancing norms and in order to ensure safety of the Members and employees of the Company during the times of COVID-19 pandemic, the AGM was being held through virtual mode.

• f. With the consent of the members, the Notice convening the 29[th] AGM and the Auditor's Report were taken as read.

• h. The Company Secretary informed that the Board had appointed Mr. Jinesh Dedhia, Practicing Company Secretary, to act as the Scrutinizer to scrutinize the remote e- voting and the votes cast at the meeting in a fair and transparent manner and to provide a consolidated report thereof.

• The Company Secretary informed that Members who did not vote earlier through remote e-voting may vote electronically during the course of the meeting.

• J. The Company Secretary then called the names of those Shareholders who had registered themselves to speak or ask questions pertaining to the performance of the Company during the Financial Year 2020-21, one by one.

• k. Clarifications were provided by the Chairman to the queries raised by the members at the meeting.

• The Company Secretary informed that results of voting would be announced on or before Saturday, 25[th] September, 2021 by intimation to the Stock Exchanges and would also be placed on the website of the Company www.marksanspharma.com.

• m. The Chairman then thanked the Members for their co-operation and declared the Meeting as closed.

• n. The following items of Ordinary and Special business as per the Notice of AGM dated August 11, 2021, were transacted through remote e-voting and through e- voting during the AGM:

• Consideration and adoption of the Standalone and Consolidated Audited Financial Statements of the Company for the financial year ended 31st March, 2021 together with the reports of the Board of Directors' and the Auditors' thereon.

• Declaration of dividend of Rs. 0.25 (i.e. 25%) on Equity Shares of Re. 1/- each face value and dividend of Rs. 7.00 (i.e. 7%) on Redeemable Cumulative Preference Shares of Rs. 100/- each face value for the financial year ended March 31, 2021.

• Re-appointment ofMr. Varddhman Vikramaditya Jain (DIN: 08338573), who retired by rotation and being eligible, offered himself for re-appointment.

• Approval of re- appointment of and Remuneration to Mr. Varddhman Vikramaditya Jain (DIN: 08338573) as a Whole-time Director of the Company.

• Approval of appointment of Dr. (Mrs.) Meena Rani Surana (DIN: 08863769) as an Independent Director of the Company.

• Approval of appointment of Mr. Sunny Sharma (DIN: 02267273) as a NonExecutive Director of the Company.

• Pursuant to the provisions of the Companies Act, 2013 and Regulation 44 of the SEBI (Listing Obligations and Disclosures Requirements), 2015, the Company had provided remote e-voting facility to its members to cast their votes electronically, on all the resolutions set out in the notice.

• Further, the facility for remote e-voting was also made available during the AGM to the members who were present at ~he AGM and had not cast their votes by remote e- voting earlier.